Status:
UNKNOWN
Efficacy and Safety Outcomes of Optometrist Performed Selective Laser Trabeculoplasty (SLT)
Lead Sponsor:
Northeastern State University
Conditions:
Primary Open-Angle Glaucoma, Unspecified Eye
Ocular Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
To measure the efficacy and safety outcomes of SLT performed by optometrists.
Detailed Description
Participants will undergo a pre-procedure examination in order to record baseline findings and to determine if they meet the inclusion criteria in order to undergo the procedure. Participants will und...
Eligibility Criteria
Inclusion
- Ability to provide written informed consent;
- At least 18 years of age, male or female, of Native American or Alaskan Native descent;
- Diagnosed with primary open angle glaucoma or ocular hypertension;
- Documented intraocular pressure greater than or equal to 23 mmHg;
- No prior glaucoma treatment unless treated with one topical drop.
Exclusion
- History of trauma or ocular surgery within the last 6 months;
- History of corneal dystrophy;
- Current use of topical or systemic steroids;
- Advanced or severe glaucomatous findings based on comprehensive examination;
- Diagnosed with other types of glaucoma such as pseudoexfoliation syndrome, pigmentary glaucoma, normal tension glaucoma, and other additional glaucoma subtypes.
Key Trial Info
Start Date :
August 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04036214
Start Date
August 21 2019
End Date
August 30 2022
Last Update
September 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northeastern State University
Tahlequah, Oklahoma, United States, 74464